Hong Pan

504 citations
22 papers · 376 indexed · h-index 10
Co-authors
Jian WuJian WangWenbin ZhouXiaoan LiuXiru WuMuxin YuLijun LingXi Wang
Topics
Cancer Immunotherapy and Biomarkers (5 papers)Cancer Cells and Metastasis (4 papers)Immunotherapy and Immune Responses (4 papers)
Partner nations
ChinaAustraliaSingapore

In The Last Decade

Hong Pan

21 papers receiving 370 citations

Peers

Hong Pan
Comparison fields: 5 of 64
  • Oncology 123
  • Molecular Biology 81
  • Hepatology 60
  • Immunology 56
  • Epidemiology 55
Replace Philip M. Keegan with:
Philip M. Keegan United States
Shaowei Lan China
Sahana Somasegar United States
Junsong Ye China
Amblessed Onuma United States
Dang Tien Truong Vietnam
Patrizio Bo Italy
Olachi J. Mezu‐Ndubuisi United States
Víctor Navarro-Tableros Italy
Veronika Kleff Germany
Hong Pan relative to Philip M. Keegan United States Philip M. Keegan's profile →
Citations per field
00.5×4.2×
Philip M. Keegan · 1×
Citations per year

Countries citing papers authored by Hong Pan

Since Specialization
Citations

This map shows the geographic impact of Hong Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Pan more than expected).

Fields of papers citing papers by Hong Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Pan. The network helps show where Hong Pan may publish in the future.

Co-authorship network of co-authors of Hong Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Pan. A scholar is included among the top collaborators of Hong Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Pan. Hong Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 4
3 53
4 1
5 1
6 9
7 0
8 39
9 8
10 7
11
Mowat-Wilson syndrome: Clinical and molecular report of the first case in mainland China
1
12 14
13 19
14 28
15 95
16 6
17 11
18 7
19 13
20 29

About Hong Pan

Hong Pan is a scholar working on Oncology, Developmental Neuroscience and Immunology, having authored 22 papers that have together received 376 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer Cells and Metastasis (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Hepatology (60 citations), Oncology (123 citations) and Obstetrics and Gynecology (29 citations). Hong Pan has collaborated with scholars based in China, Australia and Singapore. Frequent co-authors include Jian Wu, Jian Wang, Wenbin Zhou, Xiaoan Liu, Xiru Wu, Muxin Yu, Lijun Ling, Xi Wang, Binbin Wang and Qiang Ding. Their work appears in journals such as PLoS ONE, Cancer and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026